Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Non-oral methods like IUD, implant, or patch are not affected
Sematide 1mg Injection contains Semaglutide, a GLP-1 receptor agonist manufactured by Ferozsons Laboratories, designed to help control Type 2 Diabetes Mellitus, reduce the risk of major cardiovascular events, and support sustained weight management
Appetite Control: Some proponents of lipotropic injections suggest that these injections may help regulate appetite, making it easier for individuals to manage their food intake and make healthier dietary choices
Its extended lifespan of approximately seven days results from its ability to bind to albumin and resist degradation, allowing for convenient once-weekly dosing
Beneficial effects have likewise been documented with respect to cardiovascular risk factors, including hypertension (430) and dyslipidemia (431, 432)
Clinical Evidence: Weight Loss, Glucose, and Metabolic Outcomes Phase 2b and Phase 3 trials published through 2024 demonstrate retatrutide's efficacy in weight loss and glycemic control
US$ 25.45
US$ 27.44
US$ 28.11
